CN113331132A - Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin - Google Patents
Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin Download PDFInfo
- Publication number
- CN113331132A CN113331132A CN202110593883.1A CN202110593883A CN113331132A CN 113331132 A CN113331132 A CN 113331132A CN 202110593883 A CN202110593883 A CN 202110593883A CN 113331132 A CN113331132 A CN 113331132A
- Authority
- CN
- China
- Prior art keywords
- day
- capsaicin
- estrus
- cow
- rate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 title claims abstract description 148
- 241000283690 Bos taurus Species 0.000 title claims abstract description 110
- 229960002504 capsaicin Drugs 0.000 title claims abstract description 74
- 235000017663 capsaicin Nutrition 0.000 title claims abstract description 74
- 235000013336 milk Nutrition 0.000 title claims abstract description 36
- 239000008267 milk Substances 0.000 title claims abstract description 36
- 210000004080 milk Anatomy 0.000 title claims abstract description 36
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 25
- 230000012173 estrus Effects 0.000 claims abstract description 61
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 claims abstract description 33
- 230000009027 insemination Effects 0.000 claims abstract description 31
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 claims abstract description 26
- XLXSAKCOAKORKW-AQJXLSMYSA-N gonadorelin Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 XLXSAKCOAKORKW-AQJXLSMYSA-N 0.000 claims abstract description 26
- 229940035638 gonadotropin-releasing hormone Drugs 0.000 claims abstract description 26
- 230000016087 ovulation Effects 0.000 claims abstract description 24
- VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 claims abstract description 17
- 229960003248 mifepristone Drugs 0.000 claims abstract description 17
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 claims abstract description 14
- 102000011022 Chorionic Gonadotropin Human genes 0.000 claims abstract description 13
- 108010062540 Chorionic Gonadotropin Proteins 0.000 claims abstract description 13
- 230000001360 synchronised effect Effects 0.000 claims abstract description 13
- 229940084986 human chorionic gonadotropin Drugs 0.000 claims abstract description 12
- 230000001850 reproductive effect Effects 0.000 claims abstract description 11
- 238000010255 intramuscular injection Methods 0.000 claims abstract description 7
- 239000007927 intramuscular injection Substances 0.000 claims abstract description 7
- 230000013011 mating Effects 0.000 claims abstract description 4
- 230000032696 parturition Effects 0.000 claims abstract description 3
- 238000002347 injection Methods 0.000 claims description 26
- 239000007924 injection Substances 0.000 claims description 26
- 230000035935 pregnancy Effects 0.000 claims description 10
- 230000037396 body weight Effects 0.000 claims description 5
- 210000001161 mammalian embryo Anatomy 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 230000004083 survival effect Effects 0.000 claims description 4
- 229960001726 treprostinil sodium Drugs 0.000 claims description 4
- IQKAWAUTOKVMLE-ZSESPEEFSA-M treprostinil sodium Chemical compound [Na+].C1=CC=C(OCC([O-])=O)C2=C1C[C@@H]1[C@@H](CC[C@@H](O)CCCCC)[C@H](O)C[C@@H]1C2 IQKAWAUTOKVMLE-ZSESPEEFSA-M 0.000 claims description 4
- 229960005351 cloprostenol sodium Drugs 0.000 claims description 3
- IFEJLMHZNQJGQU-KXXGZHCCSA-M sodium;(z)-7-[(1r,2r,3r,5s)-2-[(e,3r)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate Chemical compound [Na+].C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC([O-])=O)OC1=CC=CC(Cl)=C1 IFEJLMHZNQJGQU-KXXGZHCCSA-M 0.000 claims description 3
- 210000003205 muscle Anatomy 0.000 claims description 2
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 claims 1
- 238000003672 processing method Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 14
- 230000008217 follicular development Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000006651 lactation Effects 0.000 description 7
- 238000009395 breeding Methods 0.000 description 6
- 230000001488 breeding effect Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 108090000371 Esterases Proteins 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 102000004895 Lipoproteins Human genes 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 4
- 230000008642 heat stress Effects 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 235000021050 feed intake Nutrition 0.000 description 3
- 230000004130 lipolysis Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 208000020207 Reproductive tract disease Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000005584 early death Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000021243 milk fat Nutrition 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 210000005000 reproductive tract Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000019100 sperm motility Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000009774 Follicular Cyst Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 210000004246 corpus luteum Anatomy 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000008011 embryonic death Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000029860 luteolysis Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 230000011599 ovarian follicle development Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Food Science & Technology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a processing method for improving the summer reproductive rate and milk yield of dairy cows by adopting capsaicin, which comprises the following steps: s1, selecting the 20 th day of postpartum cow, adding capsaicin into the daily ration, and continuously feeding for one month; s2, on the 50 th day after the dairy cow parturition, recording as the 0 th day of the synchronous estrus treatment of the dairy cow, and injecting gonadotropin releasing hormone into the healthy dairy cow in the estrus cycle; s3, on day 7, intramuscular injection of PGF2 alpha; s4, on day 9, injecting gonadotropin releasing hormone for the second time, and simultaneously injecting mifepristone to promote ovulation; s5, on the 10 th day, artificial insemination is performed; s6, injecting human chorionic gonadotropin intramuscularly at day 15, namely day 5 after artificial insemination. The invention can effectively improve the estrus rate, the mating rate and the conception rate of the postpartum dairy cows in the same period, improve the milk yield of the dairy cows and improve the milk components; and need not detect estrus, regularly insemination convenient operation.
Description
Technical Field
The invention belongs to the technical field of dairy cow breeding in animal husbandry, and particularly relates to a treatment method for improving the summer breeding rate and milk yield of dairy cows by adopting capsaicin.
Background
Although a cow is an estrus livestock throughout the year, the reproductive performance of the cow is easily affected by factors such as environment and climate. In summer, heat stress can cause the decrease of the feed intake of the dairy cows, the decrease of appetite, imbalance of energy supply and demand and influence on reproductive performance. The cow, especially the high-yield cow, is easy to cause the increase of the incidence rate of reproductive disorders such as abnormal estrus, quiet estrus, delayed ovulation, reproductive tract inflammation and the like during the postpartum lactation peak period, and can cause the increase of the early embryonic mortality rate and the increase of the proportion of frequently-bred infertile cows, thereby influencing the economic benefit of a pasture.
The estrus-timing insemination technology is widely applied to the production of dairy cows, the ovarian activity is artificially regulated and controlled and the estrus cycle and ovulation time are controlled through different combinations of reproductive hormones, the estrus identification is not needed, the operation is simple, and the conception rate of the dairy cows can be obviously improved. The Ovsynch-TAI estrus synchronization scheme is widely applied to livestock breeding, but the estrus synchronization effect in summer is not ideal, the obvious decrease of the conception rate in the estrus in summer is shown, the early death rate of embryos is increased, the main reason is that heat stress causes blood circulation on the body surface, the blood supply of digestive, reproductive and lactation systems is insufficient, the digestion, the reproduction and the lactation are influenced, the milk yield is greatly reduced, and the technical problem to be solved is urgent.
Disclosure of Invention
In order to solve the technical problems, the invention provides a treatment method for improving the summer reproductive rate and milk yield of dairy cows by adopting capsaicin, and a method for greatly improving the milk yield.
In order to achieve the purpose, the invention adopts the following technical scheme that:
a treatment method for improving the summer reproductive rate and milk yield of dairy cows by adopting capsaicin comprises the following steps:
s1, selecting the 20 th day of postpartum cow, adding capsaicin into each kilogram of daily ration, and continuously feeding for one month (30 days), wherein the day of parturition is recorded as 0 day;
s2, on the 50 th day after delivery, marking as the 0 th day of the cow synchronous estrus treatment, injecting gonadotropin releasing hormone (GnRH) into the healthy cow muscle in the estrus cycle to induce estrus;
s3, day 7, intramuscular injection of treprostinil sodium (PGF2 a) to initiate estrus;
s4, day 9, injecting gonadotropin releasing hormone (GnRH) for the second time, and simultaneously injecting mifepristone to promote ovulation;
s5, on the 10 th day, 16 hours after the mifepristone is injected, carrying out artificial insemination;
s6, at day 15, i.e. at day 5 after artificial insemination, intramuscular injection of human chorionic gonadotropin (hCG) to promote early embryo survival;
and S7, determining the pregnancy condition of the cattle by B ultrasonic on the 50 th day, namely the 40 th day after artificial insemination.
In the method, in step S1, the daily supplementary feeding amount of capsaicin is preferably 1-4 mg/kg Total Mixed Ration (TMR) daily ration.
The method as described above, preferably, the injection dose of gonadotropin releasing hormone (GnRH) is 200 μ g/head in steps S2 and S4.
The method as described above, preferably, the injection of the treprostinil sodium in step S3 is injected on day 7 after step S2. Further, the injection dosage of the PGF2 alpha is 0.5 mg/head.
The method as described above, preferably, in step S4, the second injection of gonadotropin releasing hormone GnRH is separated from the first injection by 9 days.
The method as described above, preferably, in step S4, the injectable dose of mifepristone is 0.4mg/kg body weight.
In the method as described above, preferably, in step S6, the hCG is injected in a dose of 2000 IU/head.
The application of capsaicin in increasing the conception rate of the cow in summer and increasing the milk yield.
The application is that 1-4mg of the capsaicin is added into TMR per kg of the cow on the 20 th day (day 0 of delivery) before the estrus treatment in the same period, and the cow is continuously fed for one month (30 days); on the 50 th day after delivery, namely the 0 th day of the same estrus treatment of the cows, the gonadotropin releasing hormone GnRH is injected intramuscularly in the afternoon, the cloprostenol sodium PGF2 alpha is injected intramuscularly in the afternoon on the 7 th day, the gonadotropin releasing hormone GnRH is injected intramuscularly in the afternoon on the 9 th day, mifepristone is injected at the same time, the artificial insemination is carried out in the afternoon on the 10 th day (16 hours after the mifepristone is injected), hCG is injected intramuscularly in the cattle to be bred on the 15 th day (namely the 5 th day after the artificial insemination), and the pregnancy condition of the cattle is determined by B ultrasonic on the 50 th day (namely the 40 th day after the artificial insemination).
Preferably, the capsaicin is added into one kilogram of TMR and is continuously fed for 30 days, wherein the amount of the capsaicin is 1-4 mg; the injection dosage of the gonadotropin releasing hormone GnRH is 200 mug/head; the injection dosage of the PGF2 alpha is 0.5 mg/head; the injection dosage of the mifepristone is 0.4mg/kg body weight; the injection dosage of the human chorionic gonadotropin hCG is 2000 IU/head.
In the research process, the invention discovers that the effect of low capsaicin supplementary feed amount is not obvious, the feeding cost is increased and the feed intake of the dairy cow is reduced, and the effect of high capsaicin supplementary feed amount is not stronger than that of 1-4 mg/kg daily ration and is not very good, so that the optimal dosage of capsaicin is 1-4 mg/kg daily ration, and the optimal dosage is 4mg/kg daily ration.
The dosage of gonadotropin releasing hormone (GnRH) on the dairy cattle is 50-250 mu g/head generally, but the optimal dosage of the gonadotropin releasing hormone (GnRH) injected into the dairy cattle is 200 mu g/head in the research process, the ovulation rate is influenced by too low dosage, the economic investment is increased by too high dosage, and the ovulation of multiple follicles is easily caused by too high dosage. Human chorionic gonadotropin (hCG) is injected intramuscularly, the optimal injection dose is 2000 IU/head, and the low dose or the high dose is not good for the survival of early embryo. The PGF2 alpha intramuscular injection dosage of the invention is 0.5 mg/head, and if the dosage is too low, incomplete luteolysis can be caused, and the synchronous estrus rate is influenced.
The invention has the beneficial effects that:
the processing method for improving the summer reproductive rate and milk yield of the dairy cows by adopting the capsaicin organically combines the capsaicin and GPGMH synchronous estrus method, promotes the blood circulation of a digestive system, a reproductive system and a lactation system, increases energy intake, relieves energy negative balance, further promotes follicular development and ovulation, not only can improve the synchronous estrus rate, mating rate and conception rate of the dairy cows in summer, but also can obviously improve the milk yield of the dairy cows, improve milk components, and obviously improve total solid matters, lactose content, protein content and butter fat rate, further saves the breeding cost and improves the breeding benefit.
The invention provides a new application of capsaicin, and the capsaicin can promote blood circulation if added into feed, improve digestion and relieve energy negative balance by promoting the blood circulation of digestive tract, reproductive tract and lactation system, further promote follicular development and ovulation, promote lactation and the like, and broaden the utilization rate of capsaicin.
Drawings
FIG. 1 is a flow chart of the method of the present invention for simultaneous estrus and timing insemination using capsaicin + GPGMH.
Fig. 2 shows the follicular development law of daily ration of Holstein cows with different dosages of capsaicin.
FIG. 3 is a graph of the effect of different doses of capsaicin on milk production performance.
Detailed Description
The following examples are intended to further illustrate the invention but should not be construed as limiting it. Modifications and substitutions may be made thereto without departing from the spirit and scope of the invention.
The experimental results of the present invention were obtained in summer, and the technical means used in the examples are conventional means well known to those skilled in the art, unless otherwise specified.
Example 1
In the test, 1-4mg of capsaicin is added into each kilogram of TMR of the postpartum dairy cow to research the influence of the capsaicin on the follicular development, the oestrus rate, the conception rate, the lactation rate and the blood biochemical indexes of the dairy cow so as to improve the conception rate of the dairy cow in summer and improve the milk yield of the dairy cow. 101 healthy perinatal cows with good body conditions are selected, cows on the 20 th day after delivery (day of delivery is recorded as 0 day) are selected, divided into 4 groups (the indexes of weight, age, fetal number, milk yield and the like are evenly distributed in each group), and fed with daily ration prepared by adding 0, 2, 4 and 6mg of capsaicin to each kilogram of TMR for one month (30 days). In the test I group, 2mg of capsaicin is added into each kilogram of TMR from 20 days after delivery, and supplementary feeding is continuously carried out for 30 days from 20 days after delivery to 50 days after delivery; in group II, 4mg of capsaicin is added into each kilogram of TMR from 20 days after delivery, and supplementary feeding is continuously carried out for 30 days from 20 days after delivery to 50 days after delivery; group III, starting 20 days after delivery, adding 6mg of capsaicin into each kilogram of TMR, and continuously feeding for 30 days from 20 days after delivery to 50 days after delivery; the control group did not add capsaicin. On the 50 th day after delivery, the 0 th day of the cow synchronous oestrus treatment is counted, GnRH is injected intramuscularly in the afternoon, cloprostenol sodium PGF2 alpha is injected intramuscularly in the afternoon on the 7 th day, GnRH is injected intramuscularly in the afternoon on the 9 th day, mifepristone is injected simultaneously, artificial insemination is performed in the afternoon on the 10 th day (16 hours after the mifepristone is injected), hCG is injected intramuscularly in a cow to be bred on the 15 th day (5 days after the artificial insemination), pregnancy of the cow is determined by B ultrasonic on the 50 th day (40 days after the artificial insemination, and dry matter feed intake, milk yield, milk components, serum biochemical indexes, oxidation resistance indexes, oestrus rate, ovulation rate and conception rate of the cow are respectively measured. The method comprises the following specific steps:
cows at 20 days after birth (day of delivery is recorded as 0 day) were selected, divided into 4 groups (note that the body weight, age, fetal number, milk production, etc. are evenly distributed among each group), and fed with daily ration containing 0, 2, 4, 6mg capsaicin per kg TMR for one month (30 days). On the 50 th day after delivery, the cow is counted as the 0 th day of the contemporaneous estrus treatment, GnRH is injected intramuscularly in the afternoon (200 mu g/head), B ultrasonic examination is carried out from the 6 th day (one day before PGF2 alpha injection) to the 12 th day of ovulation (namely 72h after the second GnRH injection), and follicular development, estrus and ovulation conditions are recorded; the results are shown in Table 1, where the animals were injected intramuscularly at PGF2 a on day 7 afternoon, at 0.5 mg/head, with GnRH (200. mu.g/head) a second intramuscular injection at day 9 afternoon (48 hours after PGF2 a injection), with mifepristone injection, with artificial insemination at day 10 afternoon (16 hours after mifepristone injection), and with hCG injected intramuscularly at day 15 (i.e. day 5 after artificial insemination) into the cattle to be bred. Considering the problem of early embryonic death, pregnancy diagnosis was performed on day 40 after artificial insemination, and the whole flow chart is shown in fig. 1.
1.1 Effect of different doses of capsaicin on cow follicular development
The experimental results from table 1 show that with different doses of capsaicin added to the daily ration of hestan cows, the maximum follicle diameter (13.8 ± 0.4mm) in the medium dose group (4mg/kg) is significantly (p <0.05) greater than that in the blank group (0 capsaicin is 0 group, 11.5 ± 1.5mm), but there is no significant difference in the other dose groups. The interval between the second GnRH injection and the ovulation, the interval between the second GnRH injection and the estrus duration are not different obviously among different groups (p is more than 0.05), which indicates that the simultaneous estrus treatment of the dairy cows is not influenced by the supplementary feeding of the capsaicin.
TABLE 1 Effect of supplemental feeding of different doses of capsaicin on the ovarian follicle development and oestrus duration of cows
Note: the same index, the same row with different lower case letters shows significant difference (P <0.05)
1.2 Effect of capsaicin on the estrus, ovulation and conception rates of cows after estrus synchronization
The oestrus rate, ovulation rate, conception rate and follicle growth rate of the cows after being fed with different dosages of capsaicin are shown in table 2, and the results show that the oestrus rate, ovulation rate, conception rate and follicle growth rate of the cows can be effectively improved by adding 4mg/kg of capsaicin into daily ration of the holstein cows in summer, wherein the oestrus rate of the holstein cows is 78.6% (22/28), the ovulation rate is 75.0% (21/28), the conception rate is 53.6% (15/28), the follicle growth rate reaches 1.6192mm/day, and the p is obviously (p <0.05) higher than that of other dosages.
After capsaicin with different dosages is added into daily ration of Holstein cows for pretreatment, a GPGMH synchronous estrus program is adopted to induce the cows to estrus, and the follicular development rule after synchronous estrus treatment is researched, wherein the result is shown in figure 2, and the result shows that the follicular development comparison rule (p is more than 0.05) of a medium-dose group (4 mg/kg).
TABLE 2 oestrus rate, ovulation rate, conception rate and follicular growth rate of cows fed with different doses of capsaicin
Note: the same index, the same row with different lower case letters shows significant difference (P <0.05)
1.3 influence of capsaicin addition to Dairy cow diet on milk production
After different dosages of capsaicin are added into daily ration of the Holstein cows, the daily milk yield of the cows is shown in table 3, and the results show that the daily milk yield of the cows of a medium dosage (4mg/kg) group is obviously higher than that of the cows of other dosage groups and a control group (P <0.05) from 20 days after the capsaicin is added. It is shown that the addition of capsaicin to the daily ration of a Holstein cow after delivery can increase the milk yield, wherein the addition of a medium dose (4mg/kg) of capsaicin per day to the daily ration from 20 days after delivery has a more pronounced effect on increasing the milk yield (see FIG. 3).
TABLE 3 daily milk yield of cows at various stages after different dosages of capsaicin
Note: the same index, the same row with different lower case letters shows significant difference (P <0.05)
1.4 Effect of capsaicin added into daily ration on biochemical indexes of milk cow serum
The results of the serum biochemical indexes of the cows after the cows are fed with capsaicin in different doses are shown in the table 4, and the results show that the indexes of blood sugar, lipoprotein esterase and glutamic-oxalacetic transaminase of each treatment group and the control group have no significant difference (P is more than 0.05) on the day before the same estrus (namely the 29 th day of capsaicin feeding). On the day of mating (i.e., day 40 of capsaicin addition), the blood glucose levels in the medium (4mg/kg) and high (6mg/kg) dose-treated groups were significantly higher than those in the control and low dose-treated groups (P < 0.05); the level of the lipoprotein esterase of the dairy cow in each dose treatment group is obviously higher than that of a control group (P <0.05), and no obvious difference exists among the treatment groups; the aspartate aminotransferase was significantly higher in the medium dose (4mg/kg) treated group than in the low dose (2mg/kg) and control groups (P < 0.05).
Although the cows were in negative energy balance during heat stress in general, heat stress inhibited lipolysis and maintained a low blood sugar level in the cows, while lipoprotein esterase was involved in lipolysis, lipoprotein esterase in each dose group was significantly higher than that in the control group, and blood sugar in the medium dose group (4mg/kg) and the high dose group (6mg/kg) was significantly higher than that in the control group and the low dose group (2mg/kg), indicating that capsaicin was able to promote lipolysis and increase blood sugar by gluconeogenesis. A change in aspartate aminotransferase indicates a return to normal tissue metabolism. In conclusion, the chilli extract is added into daily ration in summer, so that blood circulation can be promoted, negative effects of energy negative balance can be relieved, the metabolic function of the dairy cow is maintained, and the milk yield of the dairy cow is improved.
TABLE 4 serum biochemical index of cow after feeding cow with capsaicin of different dosage
Note: the same index, shoulder-noted different lower case letters on the same row indicates significant difference (P < 0.05).
1.5 Effect of capsaicin addition to Dairy cow diet on milk composition
The results are shown in Table 5, and show that the lactose content of the high dose group (6mg/kg) and the control group is significantly higher (P <0.05) than that of the medium dose group (4mg/kg) and the low dose group (2 mg/kg); the urea nitrogen in the low dose group (2mg/kg) and the high dose group (6mg/kg) was significantly higher than in the control group (P < 0.05). On day 30 of supplementary capsaicin feeding, the lactose content in the low dose group (2mg/kg) and the high dose group (6mg/kg) was significantly higher than that in the control group (P < 0.05); there was no significant difference in total solid and urea nitrogen for each group. The milk fat rate of the low dose (2mg/kg) and medium dose (4mg/kg) groups on days 20 and 30 after the supplementary feeding of capsaicin was significantly higher (P <0.05) than that of the control group and high dose (6mg/kg) groups. There was no significant change in milk protein rate and somatic cell number during the experiment.
TABLE 5 Effect of different doses of capsaicin on cow milk ingredients
Note: the same index, the same row with different lower case letters shows significant difference (P <0.05)
Example 2
A treatment method for increasing the summer reproduction rate and milk yield and quality of dairy cows by adding capsaicin into daily ration is characterized in that healthy dairy cows without reproductive tract diseases are selected and can be carried out according to the flow shown in figure 1, and the specific scheme is as follows:
selecting a cow on the 20 th day after delivery (0 day on the day of delivery), adding 1-4mg of capsaicin into each kilogram of TMR, and feeding for one month (30 days).
Day 0: on day 50 postpartum (first week), one or more healthy cows in the oestrus cycle are given monday afternoon 15: 00A first injection of GnRH was administered intramuscularly at a dose of 200. mu.g/head to induce estrus.
Day 6: on day 56 after delivery, ultrasound B examination was performed from day 6 of estrus synchronization (day before PGF2 a injection) to day 12 of ovulation (i.e. 72h after GnRH injection), and follicular development, estrus, and ovulation status were recorded.
Day 7: on postnatal day 57 (week two), monday afternoon 15: 00 intramuscular injection of PGF2 alpha at a dose of 0.5 mg/head to dissolve the corpus luteum to initiate oestrus.
Day 9: on postnatal day 59 (week two), wednesday afternoon 15: 00A second intramuscular GnRH (200. mu.g/head) was injected simultaneously with mifepristone (0.4mg/kg) to promote ovulation.
Day 10: on day 60 postpartum (week two), thursday afternoon 15: 00 artificial insemination is performed.
Day 15: on day 65 postpartum (third week), tuesday afternoon 15: 00 (i.e., day 5 after artificial insemination), the vaccinated cattle were injected intramuscularly with hCG (2000 IU/head) to promote early embryo survival.
Day 50: at day 100 postpartum (sixth week, friday) (i.e. day 40 after artificial insemination) 10 am: 00 diagnosis of pregnancy by B-ultrasound.
It should be noted that:
1. the capsaicin is added into daily ration by uniformly mixing TMR, and continuously feeding capsaicin for 30 days from 20 days to 50 days.
2. Rectal examination was performed before the test, and cattle with reproductive tract diseases (bilateral uterine horn with asymmetric size, follicular cyst, ovarian cyst, large uterine horn and inflammation) could not be used for the test.
3. Before each artificial insemination, alcohol is used for disinfecting the semen deposition gun, potassium permanganate disinfectant (0.1mol/L) is used for disinfecting the vulva part, and the artificial insemination personnel ensure that fingernails are cut short; the insemination technology is mastered practically, and the disposable insemination gun sleeve is used.
4. When the semen is unfrozen, the action is rapid, the unfreezing temperature is 37.5 ℃, the sperm motility is examined by a microscope, and the sperm motility is higher than 0.3 after the semen is unfrozen.
5. Strict prohibition on the use of expired hormones; the injection uses a disposable syringe.
6. And (5) observing the oestrus and ovulation conditions of the cattle, and making a record.
7. Strictly according to the scheme.
In the operation of the synchronous estrus timing insemination scheme, because the problem of early death of the embryo is considered, the first pregnancy diagnosis is determined by observing whether the cow returns estrus or not, and in order to further improve the diagnosis accuracy, the pregnancy diagnosis is that the pregnancy condition of the cow is determined and recorded by using B ultrasonic on the 40 th day after artificial insemination.
The utilization of the invention can improve the estrus rate of reproductive cows by combining the capsaicin supplementary feeding of hybrid cows after summer and delivery with GPGMH synchronous estrus treatment, and the ovulation rate and the conception rate are respectively 78.6 percent, 75.0 percent and 53.6 percent. And the cow is treated by the traditional GPG synchronous estrus scheme, and the estrus rate, the ovulation rate and the conception rate of the cow are respectively 63.0%, 55.6% and 33.3%. In terms of production performance, the milk yield is increased by 4mg/kg (P is more than 0.05) in the medium dose group and is increased by 26.67 percent compared with the control group at 20 th and 25 th days after capsaicin addition.
The effect of daily ration prepared by adding 4mg of capsaicin into each kilogram of TMR is the best (P is less than 0.05) when the milk cow is fed with capsaicin for the second 20 days after delivery and 50 days after delivery. The postpartum cow capsaicin supplementary feeding can obviously improve the indexes of milk protein rate, milk fat rate, lactose rate and the like in 30 days, the urea nitrogen level in milk is reduced, the blood sugar level is increased, and the milk production performance of cows is improved. Therefore, the method can obviously improve the breeding rate of the dairy cows. Moreover, the invention has convenient operation, does not need estrus identification, is a programmed synchronous estrus timing insemination scheme and is convenient for popularization and application.
Claims (10)
1. A treatment method for improving the summer reproductive rate and milk yield of dairy cows by adopting capsaicin is characterized by comprising the following steps:
s1, selecting the 20 th day of postpartum cow, adding capsaicin into the daily ration, and continuously feeding for one month, wherein the day of parturition is recorded as 0 day;
s2, on the 50 th day after delivery, marking as the 0 th day of the cow synchronous estrus treatment, injecting gonadotropin releasing hormone into the healthy cow muscle in the estrus cycle to induce estrus;
s3, day 7, intramuscular injection of treprostinil sodium to initiate estrus;
s4, on day 9, injecting gonadotropin releasing hormone for the second time, and simultaneously injecting mifepristone to promote ovulation;
s5, on the 10 th day, 16 hours after the mifepristone is injected, carrying out artificial insemination;
s6, injecting human chorionic gonadotropin intramuscularly at day 15, namely day 5 after artificial insemination, so as to promote the survival of early embryo;
and S7, determining the pregnancy condition of the cattle by B ultrasonic on the 50 th day, namely the 40 th day after artificial insemination.
2. The treatment method according to claim 1, wherein in step S1, the one-day supplementary feeding amount of capsaicin is 1-4mg of capsaicin per kg of TMR.
3. The treatment method according to claim 1, wherein the injection dose of gonadotropin releasing hormone is 200 μ g/head.
4. The process of claim 1, wherein the injection dosage of the treprostinil sodium is 0.5 mg/head in step S3.
5. The process of claim 1, wherein in step S4, the injectable dose of mifepristone is 0.4mg/kg body weight.
6. The process of claim 1, wherein in step S6, the hCG is injected in a dose of 2000 IU/head.
7. The application of capsaicin in increasing the conception rate of the cow in summer and increasing the milk yield.
8. The use according to claim 7, wherein the capsaicin is added at 1-4mg per kg TMR to a cow on the 20 th day after the estrus treatment and fed continuously for one month; on the 50 th day after delivery, the cow is marked as the 0 th day of the contemporaneous estrus treatment of cows, the gonadotropin releasing hormone GnRH is injected intramuscularly in the afternoon, the cloprostenol sodium PGF2 alpha is injected intramuscularly in the afternoon on the 7 th day, the gonadotropin releasing hormone GnRH is injected intramuscularly in the afternoon on the 9 th day, mifepristone is injected at the same time, the artificial insemination is performed in the afternoon on the 10 th day, the hCG is injected intramuscularly in the cattle after mating on the 15 th day, and the pregnancy condition of the cattle is determined by the type-B ultrasonic on the 50 th day.
9. The use according to claim 8, wherein the capsaicin is added at 4mg per kg TMR in cows on day 20 immediately after estrus treatment.
10. The use of claim 8, wherein the injectable dose of gonadotropin releasing hormone, GnRH, is 200 μ g/head; the injection dosage of the PGF2 alpha is 0.5 mg/head; the injection dosage of the mifepristone is 0.4mg/kg body weight; the injection dosage of the human chorionic gonadotropin hCG is 2000 IU/head.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110593883.1A CN113331132B (en) | 2021-05-28 | 2021-05-28 | Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110593883.1A CN113331132B (en) | 2021-05-28 | 2021-05-28 | Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113331132A true CN113331132A (en) | 2021-09-03 |
CN113331132B CN113331132B (en) | 2022-06-21 |
Family
ID=77471982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110593883.1A Active CN113331132B (en) | 2021-05-28 | 2021-05-28 | Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113331132B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114128668A (en) * | 2021-11-24 | 2022-03-04 | 华中农业大学 | Processing method for improving synchronous estrus-timing insemination effect of buffalo in summer |
CN114145878A (en) * | 2021-12-09 | 2022-03-08 | 华中农业大学 | Processing method for synchronous estrus-timing insemination of young buffalos |
CN116098938A (en) * | 2022-12-30 | 2023-05-12 | 安徽科技学院 | Treatment method for improving milk cow reproduction rate and milk yield by adopting Chinese herbal medicine preparation and application |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101897397A (en) * | 2010-07-28 | 2010-12-01 | 新疆维吾尔自治区畜牧科学院草业研究所 | Ration preparation technology for fattening beef cattle resistant to low temperature and moisture climatic conditions |
US20160324916A1 (en) * | 2003-10-03 | 2016-11-10 | Thorn Bioscience Llc | Process for the synchronization of ovulation for timed breeding without heat detection |
CN109431647A (en) * | 2018-09-20 | 2019-03-08 | 华中农业大学 | A kind of processing method of hybridization buffalo estrus synchronization-timing semen deposition |
CN109645234A (en) * | 2019-01-28 | 2019-04-19 | 广州立达尔生物科技股份有限公司 | A kind of lick brick for ruminant and the preparation method and application thereof |
CN110353114A (en) * | 2019-08-22 | 2019-10-22 | 南京泛成生物科技有限公司 | A kind of cow feed additive and its preparation process |
CN110368132A (en) * | 2019-06-24 | 2019-10-25 | 华中农业大学 | A kind of raising cow in summer estrus synchronization-timing semen deposition effect processing method |
-
2021
- 2021-05-28 CN CN202110593883.1A patent/CN113331132B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160324916A1 (en) * | 2003-10-03 | 2016-11-10 | Thorn Bioscience Llc | Process for the synchronization of ovulation for timed breeding without heat detection |
CN101897397A (en) * | 2010-07-28 | 2010-12-01 | 新疆维吾尔自治区畜牧科学院草业研究所 | Ration preparation technology for fattening beef cattle resistant to low temperature and moisture climatic conditions |
CN109431647A (en) * | 2018-09-20 | 2019-03-08 | 华中农业大学 | A kind of processing method of hybridization buffalo estrus synchronization-timing semen deposition |
CN109645234A (en) * | 2019-01-28 | 2019-04-19 | 广州立达尔生物科技股份有限公司 | A kind of lick brick for ruminant and the preparation method and application thereof |
CN110368132A (en) * | 2019-06-24 | 2019-10-25 | 华中农业大学 | A kind of raising cow in summer estrus synchronization-timing semen deposition effect processing method |
CN110353114A (en) * | 2019-08-22 | 2019-10-22 | 南京泛成生物科技有限公司 | A kind of cow feed additive and its preparation process |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114128668A (en) * | 2021-11-24 | 2022-03-04 | 华中农业大学 | Processing method for improving synchronous estrus-timing insemination effect of buffalo in summer |
CN114145878A (en) * | 2021-12-09 | 2022-03-08 | 华中农业大学 | Processing method for synchronous estrus-timing insemination of young buffalos |
CN116098938A (en) * | 2022-12-30 | 2023-05-12 | 安徽科技学院 | Treatment method for improving milk cow reproduction rate and milk yield by adopting Chinese herbal medicine preparation and application |
Also Published As
Publication number | Publication date |
---|---|
CN113331132B (en) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113331132B (en) | Treatment method for improving summer reproduction rate and milk yield of dairy cows by adopting capsaicin | |
Wathes et al. | Heifer fertility and carry over consequences for life time production in dairy and beef cattle | |
Roche et al. | Nutrition× reproduction interaction in pasture-based systems: is nutrition a factor in reproductive failure? | |
CN110368132B (en) | Treatment method for improving synchronous estrus-timing insemination effect of dairy cows in summer | |
CN109431647B (en) | Processing method for simultaneous estrus and timing semen deposition of hybrid buffalo | |
Titi et al. | Effect of dietary fat supplementation on reproductive performance of goats | |
CN114128668A (en) | Processing method for improving synchronous estrus-timing insemination effect of buffalo in summer | |
CN114681099A (en) | Processing method for improving synchronous estrus-timing insemination effect of buffalo in summer | |
Evans et al. | Harnessing the value of reproductive hormones in cattle production with considerations to animal welfare and human health | |
Sah et al. | A clinical study of anestrus buffaloes in Southern Nepal | |
Hamid et al. | Effects of GnRH on conception rate at the time of artificial insemination in crossbred dairy cows | |
Tomita et al. | Effects of short-term dietary supplementation on the number of ovarian follicles, quantity and quality of oocytes, and in vitro embryo production in Japanese Black cows | |
Ochea et al. | The effect of epidural administration of FSH in bovine superovulation protocol. | |
CN116098938A (en) | Treatment method for improving milk cow reproduction rate and milk yield by adopting Chinese herbal medicine preparation and application | |
Ashour et al. | Application of different hormonal protocols for improving reproductive performance of Barki ewes | |
Butler | Dairy cow reproduction | |
Everaert et al. | Effects of post-weaning altrenogest treatment in primiparous sows | |
Metodiev | Synchronization of estrus through various shorter progestagen treatments and synthetic analogue of PGF 2α in ewes from Ile de France breed. | |
Aritonang | The effect of forage energy level on production and reproduction performances of Kosta female goat | |
Aidismen et al. | The utilization of different protein sources as soybean meal substitution in the flushing diet on reproductive performances of doeling | |
CN117981715B (en) | Batch breeding method for replacement gilts for promoting initial estrus starting and improving estrus disorder of replacement gilts | |
Boro et al. | Assessment of Suitable Fixed Timed Artificial Insemination Protocols for Therapeutic Management of Post-Partum Anestrous Cow in the Foothill of Eastern Himalaya | |
Ciornei et al. | The New Method for Increasing the Genetic Potential in a Nucleus of Romanian Buffaloes, by Unicornual Artificial Insemination with Sexed Semen, after Stimulation with OvSynch Protocol | |
Patil et al. | A review on recent oestrus synchronisation programs available for farm animals | |
Kara et al. | Determining the optimum voluntary waiting period and synchronization protocol in Simmental cows |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |